1 year return (CAGR)
30.54%
Dyne Therapeutics Inc Exchange (NASDAQ, USD)
DYN
16.23
+0.02 (+0.12%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
22.78%
5 year return (CAGR)
1.90%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.20B
Price/Sales
-
Ent value
2.82B
Price/Book
4.56
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-3.39%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 17.39 |
| Daily high | 17.59 |
| Daily low | 17.06 |
| Daily Volume | 2.63M |
| All-time high | 47.04 |
| 1y analyst estimate | 39.40 |
| Beta | 1.08 |
| EPS (TTM) | -3.14 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| DYN | S&P500 | |
| Current price drop from All-time high | -65.50% | -1.29% |
| Highest price drop | -85.52% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -50.66% | -10.68% |
| Avg time to new high | 76 days | 12 days |
| Max time to new high | 839 days | 1805 days |
News
